LRP8‐deficient tumors showed a marked decrease in tumor growth and, compared with LRP8 proficient cells, showed a significantly increased overall survival of mice (76d ± vs. 31d ±, defined by reaching termination criteria) with a median survival of 29 days vs. 40 days (Fig 4B–D). This evidence concerns the gene LRP8 and neoplasm.